$JNJ Recent News Dow ekes out a gain, but S&P
Post# of 74540
Posted On: 07/16/2014 9:55:04 AM
$JNJ Recent News
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis
Medtronic-Covidien deal raises the stakes in medical-device universe 11:49 a.m. June 16, 2014 - blogs.marketwatch.com
Medtronic, Covidien in $40 billion merger talks: WSJ 1:02 p.m. June 14, 2014 - Dana Cimilluca
Where oh where has the liquidity gone? Goldman Sachs has an answer 12:38 p.m. June 13, 2014 - blogs.marketwatch.com
Picking winners from the Dow 10:23 a.m. May 29, 2014 - The Trading Deck
Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life (7/15/14) 6:21 a.m. Today - Seeking Alpha
Cramer's Mad Money - Take-Two Interactive Is Not A One-Trick Pony (7/15/14) 6:06 a.m. Today - Seeking Alpha
Should I Buy JNJ Stock? 3 Pros, 3 Cons 3:20 a.m. Today - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: High Hopes and Low-Expectation Stocks 8:00 p.m. July 15, 2014 - TheStreet.com
J&J's Results Lifted by Hep C Drug 6:46 p.m. July 15, 2014 - The Wall Street Journal Interactive Edition
Video; J&J Earnings Beat Estimates, But Guidance Mixed 4:00 p.m. July 15, 2014 - Investors Business Daily
Does Johnson & Johnson Belong in Your Portfolio? 3:52 p.m. July 15, 2014 - Wall St. Cheat Sheet
Retirement: Are You Exposed To False Diversification Risk? 3:47 p.m. July 15, 2014 - Seeking Alpha
The 4 Stocks That Held the DJIA Back 3:30 p.m. July 15, 2014 - 247WallSt.com
Johnson & Johnson Beats on EPS but Sags on a Technical Basis 2:07 p.m. July 15, 2014 - TheStreet.com
Should You Buy These 3 Soaring Dow Stocks? 12:52 p.m. July 15, 2014 - Wall St. Cheat Sheet
J&J Earnings Beat Estimates, But Guidance Mixed 11:10 a.m. July 15, 2014 - Investors Business Daily
Johnson & Johnson Beats on Q2 Earnings, Ups View Again - Analyst Blog 10:55 a.m. July 15, 2014 - Zacks.com
Johnson & Johnson (JNJ) Falls Despite Earnings Beat, Strong Olysio Sales 10:41 a.m. July 15, 2014 - TheStreet.com
Daily State Of The Markets: Can Earnings Season Carry The Bulls To Higher Ground? 10:15 a.m. July 15, 2014 - Seeking Alpha
More Good News to Backstop Market - Ahead of Wall Street 10:14 a.m. July 15, 2014 - Zacks.com
Dow Today: JPMorgan Chase (JPM) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 10:00 a.m. July 15, 2014 - TheStreet.com
UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook 7:05 a.m. July 15, 2014 - benzinga.com
July 15 Premarket Briefing: 10 Things You Should Know 6:43 a.m. July 15, 2014 - TheStreet.com
Stryker Continues Growth Spree via Acquisitions - Analyst Blog 6:20 p.m. July 14, 2014 - Zacks.com
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements 8:15 a.m. Today - PR Newswire - PRF
Autism Global Clinical Trials Review, H1, 2014 1:00 p.m. July 15, 2014 - PR Newswire - PRF
The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2014 Second-Quarter Results: 7:45 a.m. July 15, 2014 - PR Newswire - PRF
InvestorsObserver releases comments on Google, Johnson & Johnson, JP Morgan Chase, eBay, and KB Home 9:31 a.m. July 14, 2014 - PR Newswire - PRF
USHCC Applauds Johnson & Johnson for Joining President Obama's Supply Chain Initiative 8:56 p.m. July 11, 2014 - GlobeNewswire
Electrophysiology Devices Market (ECG, EEG, Holter Monitoring Systems, Diagnostic Electrophysiology Catheters, Pacemaker, Imaging and 3D Mapping Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 12:34 p.m. July 10, 2014 - PR Newswire - PRF
New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo 5:00 a.m. July 10, 2014 - PR Newswire - PRF
Fortune 500 Companies Recruit Talent at CAREERS & the disABLED Magazine's Career Expo 2:01 p.m. July 8, 2014 - PR Newswire - PRF
Kony Appoints Two Industry Luminaries to Complete Executive Team 11:00 a.m. July 8, 2014 - BusinessWire - BZX
Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company 8:02 a.m. July 8, 2014 - BusinessWire - BZX
Warrant Exercise Price Revisions, Acquisitions, and Maturity Extensions - Analyst Notes on JPMorgan Chase, Leju, Gramercy Property Trust, The Carlyle Group and Credit Acceptance 6:30 a.m. July 7, 2014 - PR Newswire - PRF
Major Commercial Real Estate Transaction: Liberty Park Sold and Rebranded 5:39 p.m. July 3, 2014 - Marketwire
Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018 4:11 p.m. July 1, 2014 - PR Newswire - PRF
India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market 2:56 p.m. July 1, 2014 - PR Newswire - PRF
Cordis Corporation Launches SABER™ PTA Dilatation Catheter toComplement Portfolio of Peripheral Arterial Disease Treatments 9:01 a.m. July 1, 2014 - BusinessWire - BZX
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection 2:00 a.m. July 1, 2014 - PR Newswire - PRF
Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 4:30 p.m. June 30, 2014 - PR Newswire - PRF
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK 5:20 a.m. June 30, 2014 - PR Newswire - PRF
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis
Medtronic-Covidien deal raises the stakes in medical-device universe 11:49 a.m. June 16, 2014 - blogs.marketwatch.com
Medtronic, Covidien in $40 billion merger talks: WSJ 1:02 p.m. June 14, 2014 - Dana Cimilluca
Where oh where has the liquidity gone? Goldman Sachs has an answer 12:38 p.m. June 13, 2014 - blogs.marketwatch.com
Picking winners from the Dow 10:23 a.m. May 29, 2014 - The Trading Deck
Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life (7/15/14) 6:21 a.m. Today - Seeking Alpha
Cramer's Mad Money - Take-Two Interactive Is Not A One-Trick Pony (7/15/14) 6:06 a.m. Today - Seeking Alpha
Should I Buy JNJ Stock? 3 Pros, 3 Cons 3:20 a.m. Today - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: High Hopes and Low-Expectation Stocks 8:00 p.m. July 15, 2014 - TheStreet.com
J&J's Results Lifted by Hep C Drug 6:46 p.m. July 15, 2014 - The Wall Street Journal Interactive Edition
Video; J&J Earnings Beat Estimates, But Guidance Mixed 4:00 p.m. July 15, 2014 - Investors Business Daily
Does Johnson & Johnson Belong in Your Portfolio? 3:52 p.m. July 15, 2014 - Wall St. Cheat Sheet
Retirement: Are You Exposed To False Diversification Risk? 3:47 p.m. July 15, 2014 - Seeking Alpha
The 4 Stocks That Held the DJIA Back 3:30 p.m. July 15, 2014 - 247WallSt.com
Johnson & Johnson Beats on EPS but Sags on a Technical Basis 2:07 p.m. July 15, 2014 - TheStreet.com
Should You Buy These 3 Soaring Dow Stocks? 12:52 p.m. July 15, 2014 - Wall St. Cheat Sheet
J&J Earnings Beat Estimates, But Guidance Mixed 11:10 a.m. July 15, 2014 - Investors Business Daily
Johnson & Johnson Beats on Q2 Earnings, Ups View Again - Analyst Blog 10:55 a.m. July 15, 2014 - Zacks.com
Johnson & Johnson (JNJ) Falls Despite Earnings Beat, Strong Olysio Sales 10:41 a.m. July 15, 2014 - TheStreet.com
Daily State Of The Markets: Can Earnings Season Carry The Bulls To Higher Ground? 10:15 a.m. July 15, 2014 - Seeking Alpha
More Good News to Backstop Market - Ahead of Wall Street 10:14 a.m. July 15, 2014 - Zacks.com
Dow Today: JPMorgan Chase (JPM) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 10:00 a.m. July 15, 2014 - TheStreet.com
UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook 7:05 a.m. July 15, 2014 - benzinga.com
July 15 Premarket Briefing: 10 Things You Should Know 6:43 a.m. July 15, 2014 - TheStreet.com
Stryker Continues Growth Spree via Acquisitions - Analyst Blog 6:20 p.m. July 14, 2014 - Zacks.com
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements 8:15 a.m. Today - PR Newswire - PRF
Autism Global Clinical Trials Review, H1, 2014 1:00 p.m. July 15, 2014 - PR Newswire - PRF
The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2014 Second-Quarter Results: 7:45 a.m. July 15, 2014 - PR Newswire - PRF
InvestorsObserver releases comments on Google, Johnson & Johnson, JP Morgan Chase, eBay, and KB Home 9:31 a.m. July 14, 2014 - PR Newswire - PRF
USHCC Applauds Johnson & Johnson for Joining President Obama's Supply Chain Initiative 8:56 p.m. July 11, 2014 - GlobeNewswire
Electrophysiology Devices Market (ECG, EEG, Holter Monitoring Systems, Diagnostic Electrophysiology Catheters, Pacemaker, Imaging and 3D Mapping Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 12:34 p.m. July 10, 2014 - PR Newswire - PRF
New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo 5:00 a.m. July 10, 2014 - PR Newswire - PRF
Fortune 500 Companies Recruit Talent at CAREERS & the disABLED Magazine's Career Expo 2:01 p.m. July 8, 2014 - PR Newswire - PRF
Kony Appoints Two Industry Luminaries to Complete Executive Team 11:00 a.m. July 8, 2014 - BusinessWire - BZX
Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company 8:02 a.m. July 8, 2014 - BusinessWire - BZX
Warrant Exercise Price Revisions, Acquisitions, and Maturity Extensions - Analyst Notes on JPMorgan Chase, Leju, Gramercy Property Trust, The Carlyle Group and Credit Acceptance 6:30 a.m. July 7, 2014 - PR Newswire - PRF
Major Commercial Real Estate Transaction: Liberty Park Sold and Rebranded 5:39 p.m. July 3, 2014 - Marketwire
Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018 4:11 p.m. July 1, 2014 - PR Newswire - PRF
India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market 2:56 p.m. July 1, 2014 - PR Newswire - PRF
Cordis Corporation Launches SABER™ PTA Dilatation Catheter toComplement Portfolio of Peripheral Arterial Disease Treatments 9:01 a.m. July 1, 2014 - BusinessWire - BZX
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection 2:00 a.m. July 1, 2014 - PR Newswire - PRF
Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 4:30 p.m. June 30, 2014 - PR Newswire - PRF
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK 5:20 a.m. June 30, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼